Mint lozenge and water additive tested for microbiome impact in 595-Person study
NCT ID NCT07451782
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study enrolled 595 adults aged 18 to 80 to see how two marketed oral hygiene products—a dissolvable lozenge and a water additive—affect the bacteria, fungi, and viruses living in the mouth. Participants used the products daily for 60 days, and researchers analyzed saliva and oral swabs for changes in microbes, metabolites, and inflammation markers. The goal was to understand how these non-drug products might influence oral and overall health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pHossident lozenge (dietary supplement) and Protektin water additive
- What this could lead to
- If successful, this could show that simple oral hygiene products can positively shift the mouth's microbiome, potentially pointing toward better ways to support oral and whole-body health without drugs.
- What could go wrong
- This is an early-stage observational and exploratory study, not designed to prove any health benefit. The products are supplements, not medicines, so any changes may be small or not clinically meaningful. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
595 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adult (18 to 80 years old), all genders, all incomes, of any race (target of 20% non- Caucasian; 2. Non-smokers or those who have currently stopped for at least 2 years; 3. Can wear full dentures; 4. No oral antibiotic taken in the past 30 days; 5. May have gums that sometimes bleed upon brushing, flossing or eating; 6. Willing to take an investigational dental hygiene product, daily, for 60 days; 7. Must be able to read and understand the consent; 8. Must be willing to answer study questionnaires at the clinical site using a laptop; 9. Must be willing to participate in 3 onsite clinical visits. Exclusion Criteria: 1. Subject is pregnant or breastfeeding 2. Subject has been on an oral antibiotic within the previous 30 days; 3. Subject participated in a dental plaque/gingivitis/periodontal clinical trial within the previous 30 days; 4. If the subject reports an allergy to any of the ingredients listed in the ingredient safety information provided in the Appendix.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Basic science are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Comprehensive Research Group
Minneapolis, Minnesota, 55415, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New manufacturing site for RAY1225 put to the test
- Can the brain rewire when hands and eyes disagree?
- Can new imaging and genetics unlock the secrets of heart attacks?
- Brain scans reveal LSD's grip on serotonin receptors
- New blood test could spot sepsis in newborns faster
- New root canal dressings aim to cut pain and speed healing